People with CTEPH and higher PAWP may see fewer gains from BPA, though safety and survival remain similar, a study shows.

Phoenix Children's has been designated a network site member of the Pediatric Pulmonary Hypertension Network (PPHNet), ...

A recent state-of-the-art review highlighted that despite significant advances, Pulmonary Hypertension (PH) patients continue ...

Constantly being attached to home medical devices is overwhelming, but columnist Anna Jeter is also grateful for the ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

The Food and Drug Administration (FDA) has issued a warning that pulmonary hypertension has been reported in infants and newborns treated with Proglycem (diazoxide; Teva) for low blood glucose. The ...

Pulmonary hypertension (PH) is a rare group of serious but LOCALIZED medical conditions that can have full-body impacts if ...

This case report describes a woman in her late 50s with reversible pulmonary hypertension (PH) due to scurvy, a rare vitamin ...

Northbrook, IL - New guidelines for the treatment and management of pulmonary arterial hypertension (PAH) have clarified the role for calcium channel blockers in this debilitating and frequently fatal ...

When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.